Skip to content

Effect of Multimodal Opioid-free Anesthesia on Return of Bowel Function in Laparoscopic Colorectal Surgery

A Randomized Control Trial Evaluating the Utility of Multimodal Opioid-free Anesthesia on Return of Bowel Function in Laparoscopic Colorectal Surgery

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04144933
Acronym
RUMBLE
Enrollment
60
Registered
2019-10-30
Start date
2021-05-15
Completion date
2024-08-01
Last updated
2023-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Analgesics, Opioid, Anesthesia, Colorectal Surgery, Dexmedetomidine, General Anesthesia, Ketamine, Laparoscopic Surgery, Lidocaine, Opioid Free Anesthesia, Postoperative Ileus

Keywords

Opioid-free, Opioid-sparing

Brief summary

The objective of this study is to determine if an opioid-free general anesthetic (OFA) technique utilizing lidocaine, ketamine, dexmedetomidine and magnesium reduce postoperative opioid consumption and speed return of bowel function in patients undergoing elective, laparoscopic, colorectal surgery compared to traditional opioid-containing general anesthetic techniques. It is hypothesized that this intraoperative OFA regimen will reduce postoperative opioid consumption, and expedite return of bowel function in this population.

Detailed description

The objective of this trial is to determine whether an opioid-free general anesthetic can help reduce postoperative opioid consumption and speed return of bowel function in patients undergoing elective, laparoscopic, colorectal surgery when compared with traditional opioid-containing techniques.

Interventions

975 mg, 300 mg

DRUGLidocaine 1% Injectable Solution, Dexmedetomidine, Ketamine

1.5 mg/kg, 0.5 mcg/kg, 0.5 mg/kg

DRUGSevoflurane, Lidocaine 2% Injectable Solution, Ketamine, Dexmedetomidine, Magnesium Sulfate

Dose titrated to effect, 1.5 mg/kg/hr, 0.15 mg/kg/hr, 0.3 -1 mcg/kg/hr (titrated to effect), 30 mg/kg bolus over 30 minutes

DRUGLidocaine 1% Injectable Solution, Sufentanil

0.5 mg/kg, 0.25-0.5 mcg/kg (titrated to effect)

DRUGSevoflurane, Sufentanil

Dose titrated to effect, As needed (dose at anesthesiologist's discretion)

Sponsors

University of Saskatchewan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18, American Society of Anesthesiology (ASA) class I-III patients scheduled for elective laparoscopic/laparoscopic assisted colorectal surgery

Exclusion criteria

* Emergency surgery, open surgery, contraindications to laparoscopic surgery (ie. adhesions, inability to tolerate pneumoperitoneum), American Society of Anesthesiology (ASA) class 4, age \< 18, pregnant or breastfeeding women, significant cardiorespiratory/hepatic/renal disease, allergy to any study drugs, inability to consent, inability to respond to pain assessments, inability to use the patient controlled analgesia device (PCA)

Design outcomes

Primary

MeasureTime frameDescription
Time to first flatusEnd of surgery to first flatus (1-4 days)Time between the end of surgery and the movement when the patient first passes flatus

Secondary

MeasureTime frameDescription
Time to tolerance of oral intakeEnd of surgery to first oral intake (1-3 days)Time between the end of surgery to when the patient can tolerate any oral solid food intake
Total Post-Anesthetic Care Unit (PACU) opioid consumptionEnd of surgery to discharge from PACU (1-2 hours)Total amount of opioid (morphine equivalents) required in PACU
Patient Controlled Analgesia (PCA) morphine consumptionEnd of surgery to 48 hours postoperativelyTotal amount of PCA morphine (mg) required from end of surgery to 48 hours postoperatively
Time to first defecationEnd of surgery to first defecation (1-7 days)Time between the end of surgery and the moment the patient first passes stool
Visual Analogue Scale (VAS) pain scoresEnd of surgery to 48 hours postoperativelyVisual Analogue Scale (VAS) pain scores will be recorded on a scale of 0 to 10, with 0 indicating no pain, and 10 indicating extreme pain, 48 hours following surgery
Quality of recovery after surgeryEnd of surgery to time of patient discharge from hospital (2-10 days)Assessed using the Quality of Recovery (QoR) 15 questionnaire, a validated tool for measuring quality of recovery after anesthesia and surgery
Time to Post-Anesthetic Care Unit (PACU) discharge readinessEnd of surgery to PACU discharge readiness (1-3 hours)Time to Post-Anesthetic Care Unit (PACU) discharge readiness

Countries

Canada

Contacts

Primary ContactJonathan Gamble, MD
jonathan.gamble@saskhealthauthority.ca306-655-1183

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026